Goldman Sachs raised its price target on Eli Lilly to $1,413 from $1,371 and maintained a ‘Buy’ rating. ・According to Koyfin ...

Correlation between clinical efficacy and changes in inflammatory biomarkers, mucosal transcriptomic signatures, and histologic disease activity ...

In UC, duvakitug maintained high rates of clinical remission, clinical response, and endoscopic improvement at Week 44In CD, duvakitug maintained ...

EQUITABLE BUILDING DECARBONIZATION Some local households may qualify for no-cost electric appliance installations, energy ...

A gene involved in RNA processing improved aging-related cell features and extended median lifespan in a small mouse ...

VKTX advances oral VK2735 into phase III as it explores weight maintenance and faces intensifying obesity drug competition.

Eli Lilly is betting on a pediatric expansion to give it’s IL-23p19 inhibitor Omvoh an edge in the fiercely competitive ...

HR has spent the past decade redesigning the employee experience around the moments that matter. Under Payday Super, the ...

The 2026 NBAA Business Aviation Convention & Exhibition (NBAA-BACE) opened Oct. 20 in Las Vegas with “The Launch,” a celebration of business aviation’s remarkable accomplishments and pioneering spirit ...

Six hours away from Moscow, outside Boise, Dr. Becky Uranga emerged, bleary-eyed, in the early hours of the morning after an ...

A reported FAA review brings the 737-10 closer to approval. Its delay history explains why passenger flights come later.

J&J's icotrokinra hit every UC endpoint in NEJM's Oct 2026 data, and the trial design choices behind that success are ...